154 Results

People

  1. Stein
    Stein
  2. Nimer
    Nimer
  3. Tallman
    Tallman
  4. Goldberg
    Goldberg
  5. Levine
    Levine
  6. Papaemmanuil
    Papaemmanuil
  7. Rampal
    Rampal
  8. Bewersdorf
    Bewersdorf
  9. Horwitz
    Horwitz
  10. Klimek
    Klimek

Groups

  1. Department of Medicine (93)
  2. Hematologic Malignancies, Division of (82)
  3. Center for Hematologic Malignancies (81)
  4. Adult Leukemia (55)
  5. GSK Faculty (27)
  6. Hematology-Oncology Fellows (23)
  7. Executive Committee, Center for Hematologic Malignancies (18)
  8. Center for Molecular Imaging and Biotechnology (17)
  9. Tow Center for Developmental Oncology (TCDO) (17)
  10. Epidemiology and Biostatistics (16)
  1. "azacitidine"
Formats
  1. Journal Article (119)
  2. Review (20)
  3. Research Letter (7)
  4. Editorial (4)
  5. Meeting Abstract (3)
  6. Correspondence (1)
Groups
  1. Department of Medicine (93)
  2. Hematologic Malignancies, Division of (82)
  3. Center for Hematologic Malignancies (81)
  4. Adult Leukemia (55)
  5. GSK Faculty (27)
  6. Hematology-Oncology Fellows (23)

More Groups

People
  1. Eytan Stein (19)
  2. Martin Tallman (16)
  3. Jan Bewersdorf (10)
  4. Stephen Nimer (10)
  5. Aaron Goldberg (8)
  6. Elli Papaemmanuil (8)

More People

Years
  1. 2025 (7)
  2. 2024 (14)
  3. 2023 (17)
  4. 2022 (7)
  5. 2021 (7)
  6. 2020 (8)

More Years

Publications
  1. Leukemia and Lymphoma (14)
  2. Blood Advances (10)
  3. Journal of Clinical Oncology (10)
  4. Blood (9)
  5. Blood Reviews (5)
  6. Journal of the National Comprehensive Cancer Network (5)

More Publications

Publishers
  1. American Society of Hematology (20)
  2. Taylor & Francis Group (19)
  3. Elsevier Inc. (13)
  4. American Society of Clinical Oncology (10)
  5. John Wiley & Sons (9)
  6. Nature Publishing Group (8)

More Publishers

Results (154)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Dual targeting of EZH2 and EZH1 drives exit of leukemia stem cells from quiescence and potentiates chemotherapy in acute myeloid leukemia
    Research Letter

    Akiyama, H.; Nishida, Y.; Chang, K. H.; Bedoy, A. D.; Muftuoglu, M.; Ma, W.; Basyal, M.; Hirschi, Z.; Honma, D.; Tsutsumi, S.; more...
    Blood Cancer Journal (2025)

    Fulltext@MSK | Save
  • Venetoclax–azacitidine versus azacitidine for the treatment of primary refractory or first relapsed acute myeloid leukemia. An IPC-DATAML-MSKCC retrospective study
    Correspondence

    Petit, C.; Higue, J.; Acheaibi, Z.; Gilhodes, J.; Hospital, M. A.; Devillier, R.; Bewersdorf, J.; Goldberg, A. D.; Pigneux, A.; Vey, N.; more...
    American Journal of Hematology (2025)

    Fulltext@MSK | Save
  • A patient-derived T cell lymphoma biorepository uncovers pathogenetic mechanisms and host-related therapeutic vulnerabilities
    Journal Article

    Fiore, D.; Cappelli, L. V.; Zhaoqi, L.; Kotlov, N.; Sorokina, M.; Phillip, J.; Zumbo, P.; Yoffe, L.; Ghione, P.; Wang, A.; more...
    Cell Reports Medicine (2025)

    Fulltext@MSK | Save
  • Chronic viral mimicry induction following p53 loss promotes immune evasion
    Journal Article

    Ishak, C. A.; Marhon, S. A.; Tchrakian, N.; Hodgson, A.; Yau, H. L.; Gonzaga, I. M.; Peralta, M.; Lungu, I. M.; Gomez, S.; Liang, S. B.; more...
    Cancer Discovery (2025)

    Fulltext@MSK | Save
  • Cost-effectiveness of Enasidenib versus conventional care for older patients with IDH2-mutant refractory/relapsed AML
    Journal Article

    Alhajahjeh, A.; Patel, K. K.; Shallis, R. M.; Podoltsev, N. A.; Kewan, T.; Stempel, J. M.; Mendez, L.; Huntington, S. F.; Stahl, M.; Goshua, G.; more...
    Leukemia and Lymphoma (2025)

    Fulltext@MSK | Save
  • HMA/VEN treatment modifications and associated outcomes in IDH-mutant AML
    Journal Article

    Chin, K. K.; Derkach, A.; Famulare, C.; Gupta, G. K.; Borge, P. D.; Geyer, M.; Goldberg, A. D.; Haque, T.; Park, J. H.; Roeker, L. E.; more...
    Leukemia and Lymphoma (2025)

    Fulltext@MSK | Save
  • Acute myeloid leukemia management and research in 2025
    Review

    Kantarjian, H. M.; DiNardo, C. D.; Kadia, T. M.; Daver, N. G.; Altman, J. K.; Stein, E. M.; Jabbour, E.; Schiffer, C. A.; Lang, A.; Ravandi, F.
    CA - A Cancer Journal for Clinicians (2025)

    Fulltext@MSK | Save
  • Beyond HMAs: Novel targets and therapeutic approaches
    Review

    Getz, T. M.; Bewersdorf, J. P.; Kewan, T.; Stempel, J. M.; Bidikian, A.; Shallis, R. M.; Stahl, M.; Zeidan, A. M.
    Seminars in Hematology (2024)

    Fulltext@MSK | Save
  • Acute myeloid leukemia (AML) with chromosome 3 inversion: Biology, management, and clinical outcome
    Review

    Alhajahjeh, A.; Bewersdorf, J. P.; Bystrom, R. P.; Zeidan, A. M.; Shimony, S.; Stahl, M.
    Leukemia and Lymphoma (2024)

    Fulltext@MSK | Save
  • Genetic risk classification for adults with AML receiving less-intensive therapies: The 2024 ELN recommendations
    Journal Article

    Döhner, H.; DiNardo, C. D.; Appelbaum, F. R.; Craddock, C.; Dombret, H.; Ebert, B. L.; Fenaux, P.; Godley, L. A.; Hasserjian, R. P.; Larson, R. A.; more...
    Blood (2024)

    Fulltext@MSK | Save